Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AChR Myasthenia Gravis”

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06106672

What this trial is testing

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Who this might be right for

Myasthenia GravisGeneralized MyastheniaAChR Myasthenia Gravis+1 more

COUR Pharmaceutical Development Company, Inc. 54

Large-scale testing (Phase 3)Looking for participantsNCT06607627

What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for

Generalized Myasthenia GravisgMG

Alexion Pharmaceuticals, Inc. 12

Testing effectiveness (Phase 2)Looking for participantsNCT07284420

What this trial is testing

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Who this might be right for

AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more

Not applicableLooking for participantsNCT06967480

What this trial is testing

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for

Generalized Myasthenia GravisAnti-AChR Antibody Positive

Alexion Pharmaceuticals, Inc. 40